7413-34-5

Methotrexate disodium is an tetrahydrofolate dehydrogenase inhibitor

Methotrexate-D3 (Standard) is a reference standard of Methotrexate-D3 intended for quantitative analysis, quality control, and related biochemical research applications. Methotrexate-d3 is a deuterated compound of Methotrexate. Methotrexate has a CAS number of 59-05-2. Methotrexate is a folate analog metabolic inhibitor with immunosuppressant and antineoplastic properties.

Methotrexate (Standard) is a reference standard for research and analysis in studies involving Methotrexate. Methotrexate (WR19039) is a folate analog, an inhibitor of the dihydrofolate reductase DHFR. Methotrexate has antimetabolic, antitumor, and immunosuppressive activities, and is commonly used in rheumatoid arthritis and various tumors.

Methotrexate-[13C,D3] (Standard) is a reference standard of Methotrexate-[13C,D3] intended for quantitative analysis, quality control, and related biochemical research applications.

Methotrexate (hydrate) is a useful organic compound for research related to life sciences. The catalog number is T65289 and the CAS number is 133073-73-1.

Methotrexate (WR19039) is a folate analog, an inhibitor of the dihydrofolate reductase DHFR. Methotrexate has antimetabolic, antitumor, and immunosuppressive activities, and is commonly used in rheumatoid arthritis and various tumors.

Methotrexate-D3 diammonium is the deuterated form of Methotrexate diammonium (T8003). Methotrexate (Amethopterin) functions as an antimetabolite and antifolate by inhibiting dihydrofolate reductase, which prevents the conversion of folic acid to tetrahydrofolate, thereby inhibiting DNA synthesis. It also acts as an immunosuppressant and antineoplastic agent, used in treating rheumatoid arthritis and in researching various cancers, such as acute lymphoblastic leukemia.

Methotrexate-D3 is a deuterated compound of Methotrexate. Methotrexate (T1485) has a CAS number of 59-05-2. Methotrexate (T1485) is a folate analog metabolic inhibitor with immunosuppressant and antineoplastic properties.

Methotrexate monohydrate is a DHhF reductase inhibitor. Methotrexate monohydrate increases T cell apoptosis, decreases T cell activation and suppresses cytokine production.